We use privacy-friendly analytics. Read our privacy policy.

Compound Profile

Devils Claw Extract

Devils Claw Extract is best framed as a conservative research profile with mechanistic evidence and a focus on Inflammation.

Use extra caution — GI upset possible; caution with ulcers, anticoagulants, and pregnancy. Details

Last reviewed: •2 sources citedReport a correctionProfile-wide ·D Preliminary
Devils Claw Extract monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade D
Safety
GI upset possible; caution with ulcers, anticoagulants, and pregnancy.
Profile context
Inflammation, Immune Function, Digestive Health
Next steps

Continue reading

Quick stats

Evidence level
Preliminary evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Use caution
Best for
Inflammation, Immune Function, Digestive Health
Avoid / review if
Peptic Ulcer Or Gallstones (May Increase Gastric Acid Secretion), Anticoagulant Or Antiplatelet Medications (Potential Additive Bleeding Risk), Antidiabetic Medications (May Potentiate Blood Glucose Lowering Effects)

Safety

Safety & Cautions

GI upset possible; caution with ulcers, anticoagulants, and pregnancy.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Stimulant-Like ProfileStimulant-like or activating caution language is present.
  • Anticoagulant CautionBleeding or anticoagulant-adjacent caution language is present.

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

High-Priority Caution

147 flagged pairings

Bleeding / anticoagulant risk

Moderate Caution

191 flagged pairings

Blood-sugar lowering · Blood-pressure effects

Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.

Evidence Summary

Profile-wide ·D Preliminary

Evidence lens

Early signal that needs stronger human replication before practical claims.

PreliminaryPreliminary evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation

Research maturity: Theoretical / mechanistic research — Mechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note available — GI upset possible; caution with ulcers, anticoagulants, and pregnancy.

This profile cites 2 human studies.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Preliminary evidence

Devils Claw Extract has a preliminary evidence rating.

NootropicFocusLongevity
Citation density
0.5
Sources
2
Effects
4
Research recency
Mixed recency
Evidence Grade

Grade D: Preliminary / Theoretical Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Systematic review
Risk of Bias
Low
Consistency
Not assessed
Strongest recorded design is a systematic review, drawn from 3 recorded studies, 1 in people.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (2)0 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 2 of 2 studies.

What the evidence actually shows

This table contains 2 structured sources, including 0 human evidence sources; 0 are human trials.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

Devil's Claw (Harpagophytum procumbens) as a treatment for osteoarthritis: a review of efficacy and safety

PubMed · J Altern Complement Med · 2006

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

——————PubMed →

Mutagenicity and antioxidant assessment of Stachitarpheta jamaicensis (L.) Vahl

PubMed · Phytother Res · 2001

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

——————PubMed →

How Devils Claw Extract Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Devils Claw Extract Works

How Devils Claw Extract WorksDevils Claw Extract acts on biological target pathways via anti inflammatory, leading to inflammation.Devils Claw ExtractBiological TargetBiological pathwayAnti Inflammatory↓ InflammationSystemic relief
CompoundTarget / ReceptorMechanismEffect / Outcome

Dosing

No standardized dose
No standardized dose is established for this ingredient in our source data. Preparations differ widely, so follow the standardization on the product you actually have and speak to a clinician before starting.
Mechanisms & biological pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

  • Inflammatory Signaling Modulation

Guides that use Devils Claw Extract

Continue exploring

Related research paths

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Free safety checklist

Get the Devils Claw Extract evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?